Latest / Decera Clinical Education Oncology Podcast
The Evolving Role of TKIs in First-line Treatment of Advanced HCC
In this podcast episode from Clinical Care Options (CCO), Josep M. Llovet, MD, PhD, and Markus Peck-Radosavljevic, MD, MBA, discuss first-line treatment of patients with advanced hepatocellular carcinoma. Topics include:
Atezolizumab plus bevacizumab as the current standard of care
Contraindications to atezolizumab plus bevacizumab
The current role of tyrosine kinase inhibitors in first-line treatment of advanced hepatocellular carcinoma
Ongoing clinical trials in the first-line setting
Presenters:
Josep M. Llovet, MD, PhD, FAASLD
Professor of Medicine
Director, Mount Sinai Liver Cancer…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.